At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> SEC Filings

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
4 lockhart, david j Feb 5, 2009 19.7 KB View HTML View PDF View XLS  
4 licholai, gregory p Feb 5, 2009 19.7 KB View HTML View PDF View XLS  
4 kirk, john Feb 5, 2009 19.7 KB View HTML View PDF View XLS  
4 gilmore, geoffrey Feb 5, 2009 19.8 KB View HTML View PDF View XLS  
4 dentzer, james e Feb 5, 2009 19.7 KB View HTML View PDF View XLS  
4 campbell, bradley l Feb 5, 2009 19.8 KB View HTML View PDF View XLS  
4 boudes, pol f Feb 5, 2009 19.7 KB View HTML View PDF View XLS  
4 barer, sol j Feb 5, 2009 19.6 KB View HTML View PDF View XLS  
4 dentzer, james e Feb 3, 2009 19.7 KB View HTML View PDF View XLS  
3 boudes pol f Jan 29, 2009 15.9 KB View HTML View PDF View XLS  
3 barer sol j Jan 16, 2009 15.8 KB View HTML View PDF View XLS  
4 palling, david Jan 12, 2009 20.5 KB View HTML View PDF View XLS  
8-K current report Jan 8, 2009 33.0 KB View HTML View PDF View XLS  
4 dentzer, james e Jan 5, 2009 19.7 KB View HTML View PDF View XLS  
8-K current report Dec 31, 2008 200.1 KB View HTML View PDF View XLS  
4 bloch, stephen m Dec 10, 2008 23.0 KB View HTML View PDF View XLS  
4 bloch, stephen m Dec 5, 2008 22.0 KB View HTML View PDF View XLS  
4 patterson, matthew r Dec 4, 2008 20.6 KB View HTML View PDF View XLS  
4 bloch, stephen m Dec 3, 2008 22.5 KB View HTML View PDF View XLS  
4 dentzer, james e Dec 2, 2008 19.8 KB View HTML View PDF View XLS  
Showing 301-320 of 639 Page: 1 ... 12 13 14 15 16 17 18 19 20 ... 32  Previous 20 | Next 20

Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy